A quick note from Gary… On My Way BACK from ADA

Since the purpose of Diabetes Bites is to inform and inspire as many people as possible about the latest/greatest approaches to diabetes management, I would be remiss if I failed to share a little bit about the findings from this year’s ADA Scientific Sessions.  For a full report, go to our latest blog post: 2018 ADA Scientific Sessions Report.  Don’t forget to check out the photo of yours truly (taken at Orlando’s famous “Ice Bar”) at the end of the article!

This year’s meeting was captivating, to say the least.  Type-1 diabetes seemed to receive more than its usual lack of attention.  CGM is being touted as the new standard of care (at least from a monitoring perspective), with new systems and analytics getting involved for achieving pattern recognition.  There were lots of new product launches:  Tandem’s X2 pump with predictive low glucose suspend, Insulet’s Dash programming platform, Medtronic’s Guardian Connect CGM system, and Senseonics’ three-month implantable sensor, just to name a few.  Even big pharma is getting into the type-1 scene, with oral medications (SGLT-1/2 and SGLT-2 inhibitors) that can lower overall glucose levels and delay the blood sugar rise that occurs after meals.  There was also considerable debate about the merits and drawbacks of low-carb and ketogenic diets.

With all that’s new, now would be a good time to make an appointment with your diabetes doctor or Certified Diabetes Educator.  Take full advantage of the latest findings and innovative products!  They are here to make your life better.

As always, I hope you enjoy this month’s edition of Diabetes Bites.  Your feedback is greatly appreciated.

– Gary

Gary Scheiner MS, CDE
Owner & Clinical Director